| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 9.13e-45 | 46 | 39 | 20 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 6.27e-31 | 188 | 39 | 20 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 SHANK1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 CRYBB1 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 BSN COL6A6 TTN COL1A1 COL1A2 | 3.82e-23 | 891 | 39 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 4.82e-17 | 12 | 39 | 7 | GO:0048407 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.94e-08 | 156 | 39 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | heparin binding | 1.83e-06 | 192 | 39 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.24e-05 | 268 | 39 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.35e-05 | 86 | 39 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | protease binding | 2.60e-05 | 181 | 39 | 5 | GO:0002020 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.56e-05 | 323 | 39 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.34e-04 | 51 | 39 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 9.87e-04 | 1356 | 39 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.05e-03 | 42 | 39 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | integrin binding | 4.80e-03 | 175 | 39 | 3 | GO:0005178 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.98e-23 | 377 | 39 | 19 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.13e-23 | 378 | 39 | 19 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.29e-23 | 379 | 39 | 19 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | COL2A1 COL3A1 COL5A1 COL6A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.49e-14 | 76 | 39 | 9 | GO:0030199 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.45e-11 | 12 | 39 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.56e-10 | 18 | 39 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL2A1 SHANK1 COL3A1 COL5A1 COL6A1 COL5A3 PAWR COL11A1 COL11A2 TTN COL1A1 COL1A2 | 1.14e-07 | 957 | 39 | 12 | GO:0097435 |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.80e-07 | 238 | 39 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL5A1 COL6A1 COL11A1 EPN1 TTN COL1A1 COL1A2 | 1.31e-06 | 1442 | 39 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | connective tissue development | 3.22e-06 | 343 | 39 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | cartilage development | 5.92e-06 | 243 | 39 | 6 | GO:0051216 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL3A1 COL4A1 EPHB4 SKOR1 COL4A2 COL4A3 COL4A5 COL6A1 SKOR2 COL1A1 COL1A2 | 8.17e-06 | 1186 | 39 | 11 | GO:0007167 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL5A1 ZNF385A EPN1 TTN SKOR2 COL1A1 | 1.15e-05 | 1483 | 39 | 12 | GO:0048646 |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 1.27e-05 | 161 | 39 | 5 | GO:0071230 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.62e-05 | 615 | 39 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 2.00e-05 | 177 | 39 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | sensory perception | COL2A1 SHANK1 COL4A3 CRYBB1 ZFHX2 COL6A1 PAWR COL11A1 COL11A2 COL1A1 | 2.20e-05 | 1072 | 39 | 10 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 3.42e-05 | 198 | 39 | 5 | GO:0007605 | |
| GeneOntologyBiologicalProcess | response to amino acid | 3.77e-05 | 202 | 39 | 5 | GO:0043200 | |
| GeneOntologyBiologicalProcess | blood vessel development | 4.59e-05 | 929 | 39 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | vasculature development | 6.36e-05 | 969 | 39 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | skin development | 6.62e-05 | 373 | 39 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 6.69e-05 | 228 | 39 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | limb joint morphogenesis | 7.27e-05 | 7 | 39 | 2 | GO:0036022 | |
| GeneOntologyBiologicalProcess | tendon development | 7.27e-05 | 7 | 39 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.32e-05 | 43 | 39 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL2A1 COL3A1 EPHB4 COL5A1 COL6A1 COL11A1 COL11A2 TTN COL1A1 COL1A2 | 9.22e-05 | 1269 | 39 | 10 | GO:0009887 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 9.76e-05 | 247 | 39 | 5 | GO:0009612 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 1.14e-04 | 133 | 39 | 4 | GO:0002062 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.55e-04 | 10 | 39 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.67e-04 | 277 | 39 | 5 | GO:0048705 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 1.72e-04 | 148 | 39 | 4 | GO:0032963 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 1.89e-04 | 59 | 39 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 3.30e-04 | 321 | 39 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | skin morphogenesis | 3.60e-04 | 15 | 39 | 2 | GO:0043589 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 3.84e-04 | 75 | 39 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.07e-04 | 336 | 39 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 4.44e-04 | 747 | 39 | 7 | GO:0007169 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.47e-04 | 343 | 39 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 4.47e-04 | 79 | 39 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | heart development | 4.81e-04 | 757 | 39 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of muscle | 5.84e-04 | 19 | 39 | 2 | GO:1901077 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 7.21e-04 | 93 | 39 | 3 | GO:0060415 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 8.60e-04 | 23 | 39 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | visual perception | 9.12e-04 | 230 | 39 | 4 | GO:0007601 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 9.43e-04 | 102 | 39 | 3 | GO:0048644 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 9.55e-04 | 850 | 39 | 7 | GO:0071363 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 9.57e-04 | 233 | 39 | 4 | GO:0050953 | |
| GeneOntologyBiologicalProcess | cell aggregation | 1.19e-03 | 27 | 39 | 2 | GO:0098743 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.19e-03 | 883 | 39 | 7 | GO:0070848 | |
| GeneOntologyBiologicalProcess | head development | 1.50e-03 | 919 | 39 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | bone development | 1.52e-03 | 264 | 39 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.65e-03 | 124 | 39 | 3 | GO:0060349 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 MBL2 COL1A1 COL1A2 | 5.71e-41 | 88 | 39 | 21 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A3 COL7A1 COL11A1 COL11A2 COL1A1 COL1A2 | 5.01e-35 | 21 | 39 | 14 | GO:0098644 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.03e-24 | 332 | 39 | 19 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 3.73e-22 | 530 | 39 | 20 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.55e-20 | 656 | 39 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.70e-20 | 658 | 39 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 3.35e-20 | 12 | 39 | 8 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 3.35e-20 | 12 | 39 | 8 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL7A1 COL17A1 | 2.47e-16 | 122 | 39 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.04e-13 | 6 | 39 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 9.66e-13 | 8 | 39 | 5 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 9.66e-13 | 8 | 39 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 9.66e-13 | 8 | 39 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 5.16e-11 | 5 | 39 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 PAWR COL11A1 COL11A2 TTN COL1A1 COL1A2 | 1.15e-10 | 1187 | 39 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type I trimer | 3.39e-06 | 2 | 39 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 COL3A1 COL5A1 COL6A1 COL5A3 PAWR COL11A1 COL11A2 TTN COL1A1 COL1A2 | 6.80e-06 | 1179 | 39 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | collagen type IX trimer | 2.03e-05 | 4 | 39 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | collagen type V trimer | 2.03e-05 | 4 | 39 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 5.06e-05 | 6 | 39 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.00e-03 | 155 | 39 | 3 | GO:0098685 | |
| HumanPheno | Atrophic scars | 2.56e-10 | 37 | 25 | 7 | HP:0001075 | |
| HumanPheno | Osteoarthritis | 4.12e-10 | 65 | 25 | 8 | HP:0002758 | |
| HumanPheno | Scarring | COL3A1 EPHB4 ZFHX2 COL5A1 COL6A1 COL7A1 COL17A1 COL1A1 COL1A2 | 5.68e-10 | 102 | 25 | 9 | HP:0100699 |
| HumanPheno | Atypical scarring of skin | 1.20e-09 | 74 | 25 | 8 | HP:0000987 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A3 COL4A4 CRYBB1 COL4A5 COL5A1 COL9A2 COL9A3 COL11A1 COL11A2 TCF20 NR2F1 COL1A2 | 2.38e-09 | 447 | 25 | 14 | HP:0000545 |
| HumanPheno | Abnormality of refraction | COL2A1 COL3A1 COL4A1 COL4A3 COL4A4 CRYBB1 COL4A5 COL5A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 TCF20 NR2F1 COL1A2 | 1.02e-08 | 709 | 25 | 16 | HP:0000539 |
| HumanPheno | Fragile skin | 1.54e-08 | 37 | 25 | 6 | HP:0001030 | |
| HumanPheno | Arterial rupture | 3.12e-08 | 8 | 25 | 4 | HP:0025019 | |
| HumanPheno | Vitreoretinopathy | 4.64e-08 | 22 | 25 | 5 | HP:0007773 | |
| HumanPheno | Cigarette-paper scars | 9.29e-08 | 10 | 25 | 4 | HP:0001073 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.04e-07 | 3 | 25 | 3 | HP:0030034 | |
| HumanPheno | Abnormal cornea morphology | COL3A1 COL4A1 COL4A4 CRYBB1 COL4A5 ZFHX2 COL5A1 COL7A1 COL9A2 COL9A3 COL11A1 COL17A1 NR2F1 COL1A1 COL1A2 | 2.01e-07 | 744 | 25 | 15 | HP:0000481 |
| HumanPheno | Abnormal lower limb epiphysis morphology | 2.13e-07 | 94 | 25 | 7 | HP:0006500 | |
| HumanPheno | Arteriovenous fistula | 2.18e-07 | 12 | 25 | 4 | HP:0004947 | |
| HumanPheno | Limb pain | 2.25e-07 | 57 | 25 | 6 | HP:0009763 | |
| HumanPheno | Bell-shaped thorax | 4.03e-07 | 33 | 25 | 5 | HP:0001591 | |
| HumanPheno | Cervical insufficiency | 4.16e-07 | 4 | 25 | 3 | HP:0030009 | |
| HumanPheno | Dermal atrophy | 5.22e-07 | 107 | 25 | 7 | HP:0004334 | |
| HumanPheno | Abnormal tibia morphology | 5.22e-07 | 107 | 25 | 7 | HP:0002992 | |
| HumanPheno | Knee pain | 1.03e-06 | 17 | 25 | 4 | HP:0030839 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.04e-06 | 5 | 25 | 3 | HP:0007964 | |
| HumanPheno | Platyspondyly | 1.43e-06 | 124 | 25 | 7 | HP:0000926 | |
| HumanPheno | Glomerular deposits | 2.07e-06 | 20 | 25 | 4 | HP:0030949 | |
| HumanPheno | Abnormal limb epiphysis morphology | 2.94e-06 | 138 | 25 | 7 | HP:0006505 | |
| HumanPheno | Abnormal vitreous humor morphology | 3.07e-06 | 49 | 25 | 5 | HP:0004327 | |
| HumanPheno | Molluscoid pseudotumors | 3.61e-06 | 7 | 25 | 3 | HP:0000993 | |
| HumanPheno | Dumbbell-shaped long bone | 3.61e-06 | 7 | 25 | 3 | HP:0000947 | |
| HumanPheno | Uterine prolapse | 3.61e-06 | 7 | 25 | 3 | HP:0000139 | |
| HumanPheno | Coxa valga | 3.96e-06 | 92 | 25 | 6 | HP:0002673 | |
| HumanPheno | Finger joint hypermobility | 4.15e-06 | 52 | 25 | 5 | HP:0006094 | |
| HumanPheno | Small epiphyses | 4.49e-06 | 24 | 25 | 4 | HP:0010585 | |
| HumanPheno | Irregular epiphyses | 5.33e-06 | 25 | 25 | 4 | HP:0010582 | |
| HumanPheno | Genital hernia | 5.76e-06 | 8 | 25 | 3 | HP:0100823 | |
| HumanPheno | Abnormality of hand joint mobility | 6.57e-06 | 57 | 25 | 5 | HP:0006256 | |
| HumanPheno | Dermal translucency | 7.34e-06 | 27 | 25 | 4 | HP:0010648 | |
| HumanPheno | Abnormal anterior eye segment morphology | COL2A1 COL3A1 COL4A1 COL4A3 COL4A4 CRYBB1 COL4A5 ZFHX2 COL5A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 NR2F1 COL1A1 COL1A2 | 7.66e-06 | 1450 | 25 | 18 | HP:0004328 |
| HumanPheno | Pain | COL2A1 COL3A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 TTN COL1A1 | 8.03e-06 | 846 | 25 | 14 | HP:0012531 |
| HumanPheno | Arthralgia of the hip | 8.61e-06 | 9 | 25 | 3 | HP:0003365 | |
| HumanPheno | Flat face | 9.05e-06 | 106 | 25 | 6 | HP:0012368 | |
| HumanPheno | Epiphyseal dysplasia | 9.87e-06 | 29 | 25 | 4 | HP:0002656 | |
| HumanPheno | Lenticonus | 1.23e-05 | 10 | 25 | 3 | HP:0001142 | |
| HumanPheno | Amblyopia | 1.24e-05 | 112 | 25 | 6 | HP:0000646 | |
| HumanPheno | Joint subluxation | 1.30e-05 | 31 | 25 | 4 | HP:0032153 | |
| HumanPheno | Coxa vara | 1.58e-05 | 68 | 25 | 5 | HP:0002812 | |
| HumanPheno | Arthritis | 1.62e-05 | 251 | 25 | 8 | HP:0001369 | |
| HumanPheno | Retinal detachment | 1.68e-05 | 118 | 25 | 6 | HP:0000541 | |
| HumanPheno | Small joint hypermobilty | 1.70e-05 | 69 | 25 | 5 | HP:0430046 | |
| HumanPheno | Pierre-Robin sequence | 1.90e-05 | 34 | 25 | 4 | HP:0000201 | |
| HumanPheno | Mitral valve prolapse | 2.13e-05 | 123 | 25 | 6 | HP:0001634 | |
| HumanPheno | Thickened glomerular basement membrane | 2.23e-05 | 12 | 25 | 3 | HP:0004722 | |
| HumanPheno | Arterial dissection | 2.23e-05 | 12 | 25 | 3 | HP:0005294 | |
| HumanPheno | Biconcave flattened vertebrae | 2.31e-05 | 2 | 25 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 2.31e-05 | 2 | 25 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 2.31e-05 | 2 | 25 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 2.31e-05 | 2 | 25 | 2 | HP:0005005 | |
| HumanPheno | Internal tibial torsion | 2.31e-05 | 2 | 25 | 2 | HP:0034372 | |
| HumanPheno | Bladder diverticulum | 2.39e-05 | 36 | 25 | 4 | HP:0000015 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 2.89e-05 | 13 | 25 | 3 | HP:0033282 | |
| HumanPheno | Abnormal uterine cervix morphology | 2.89e-05 | 13 | 25 | 3 | HP:0012888 | |
| HumanPheno | Abnormal femoral neck/head morphology | 3.52e-05 | 201 | 25 | 7 | HP:0003366 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 3.52e-05 | 201 | 25 | 7 | HP:0008065 | |
| HumanPheno | Glomerular subepithelial deposits | 3.67e-05 | 14 | 25 | 3 | HP:0033603 | |
| HumanPheno | Neonatal short-limb short stature | 3.67e-05 | 14 | 25 | 3 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 3.67e-05 | 14 | 25 | 3 | HP:0001027 | |
| HumanPheno | Tibial bowing | 4.04e-05 | 41 | 25 | 4 | HP:0002982 | |
| HumanPheno | Lower limb pain | 4.04e-05 | 41 | 25 | 4 | HP:0012514 | |
| HumanPheno | Knee osteoarthritis | 4.57e-05 | 15 | 25 | 3 | HP:0005086 | |
| HumanPheno | Juvenile aseptic necrosis | 4.90e-05 | 43 | 25 | 4 | HP:0100323 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 4.97e-05 | 86 | 25 | 5 | HP:0006499 | |
| HumanPheno | Abnormal knee physiology | 5.25e-05 | 87 | 25 | 5 | HP:0034670 | |
| HumanPheno | Hypoplastic ischia | 5.61e-05 | 16 | 25 | 3 | HP:0003175 | |
| HumanPheno | Abnormal mitral valve morphology | 5.65e-05 | 146 | 25 | 6 | HP:0031477 | |
| HumanPheno | Premature rupture of membranes | 6.79e-05 | 17 | 25 | 3 | HP:0001788 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 6.92e-05 | 3 | 25 | 2 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 6.92e-05 | 3 | 25 | 2 | HP:0003841 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 6.92e-05 | 3 | 25 | 2 | HP:0006201 | |
| HumanPheno | Radially deviated wrists | 6.92e-05 | 3 | 25 | 2 | HP:0006190 | |
| HumanPheno | Anterior lenticonus | 6.92e-05 | 3 | 25 | 2 | HP:0011501 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 6.92e-05 | 3 | 25 | 2 | HP:0003946 | |
| HumanPheno | Popcorn calcification | 6.92e-05 | 3 | 25 | 2 | HP:6000871 | |
| HumanPheno | Subcutaneous spheroids | 6.92e-05 | 3 | 25 | 2 | HP:0025014 | |
| HumanPheno | Thin glomerular basement membrane | 6.92e-05 | 3 | 25 | 2 | HP:0012577 | |
| HumanPheno | Proportionate short stature | 7.34e-05 | 153 | 25 | 6 | HP:0003508 | |
| HumanPheno | Corneal erosion | 7.59e-05 | 48 | 25 | 4 | HP:0200020 | |
| HumanPheno | High myopia | 7.63e-05 | 94 | 25 | 5 | HP:0011003 | |
| HumanPheno | Enlarged thorax | 7.63e-05 | 94 | 25 | 5 | HP:0100625 | |
| HumanPheno | Abnormality of lens shape | 8.12e-05 | 18 | 25 | 3 | HP:0011526 | |
| HumanPheno | Bowing of the long bones | 8.55e-05 | 316 | 25 | 8 | HP:0006487 | |
| HumanPheno | Abnormal femoral neck morphology | 9.43e-05 | 160 | 25 | 6 | HP:0003367 | |
| HumanPheno | Short limb dwarfism | 9.61e-05 | 19 | 25 | 3 | HP:0003505 | |
| HumanPheno | Dilatation of the cerebral artery | 9.66e-05 | 51 | 25 | 4 | HP:0004944 | |
| HumanPheno | Anomaly of the limb diaphyses | 9.77e-05 | 322 | 25 | 8 | HP:0006504 | |
| HumanPheno | Thin ribs | 1.04e-04 | 52 | 25 | 4 | HP:0000883 | |
| HumanPheno | Abnormal forearm morphology | 1.07e-04 | 239 | 25 | 7 | HP:0002973 | |
| HumanPheno | Malar flattening | 1.09e-04 | 240 | 25 | 7 | HP:0000272 | |
| HumanPheno | Shoulder dislocation | 1.13e-04 | 20 | 25 | 3 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 1.13e-04 | 20 | 25 | 3 | HP:0040160 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 TTN COL1A1 COL1A2 | 1.15e-04 | 653 | 25 | 11 | HP:0003272 |
| HumanPheno | Joint laxity | 1.30e-04 | 55 | 25 | 4 | HP:0001388 | |
| HumanPheno | Dwarfism | 1.31e-04 | 21 | 25 | 3 | HP:0001516 | |
| MousePheno | podocyte foot process effacement | 3.46e-08 | 38 | 35 | 5 | MP:0008140 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 7.40e-08 | 44 | 35 | 5 | MP:0011348 | |
| MousePheno | hematuria | 1.24e-07 | 19 | 35 | 4 | MP:0005161 | |
| MousePheno | abnormal podocyte foot process morphology | 2.32e-07 | 55 | 35 | 5 | MP:0008059 | |
| MousePheno | abnormal synovial joint morphology | 5.67e-07 | 124 | 35 | 6 | MP:0030804 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 7.87e-07 | 70 | 35 | 5 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 7.87e-07 | 70 | 35 | 5 | MP:0005326 | |
| MousePheno | impaired hearing | 1.10e-06 | 223 | 35 | 7 | MP:0006325 | |
| MousePheno | abnormal hearing physiology | COL2A1 COL4A3 COL4A4 COL9A2 COL9A3 COL11A1 COL11A2 BSN NR2F1 COL1A1 | 2.55e-06 | 643 | 35 | 10 | MP:0001963 |
| MousePheno | abnormal ear physiology | COL2A1 COL4A3 COL4A4 COL9A2 COL9A3 COL11A1 COL11A2 BSN NR2F1 COL1A1 | 4.44e-06 | 684 | 35 | 10 | MP:0003878 |
| MousePheno | abnormal extracellular matrix morphology | 4.64e-06 | 100 | 35 | 5 | MP:0013258 | |
| MousePheno | abnormal renal glomerular capsule morphology | 6.47e-06 | 107 | 35 | 5 | MP:0002828 | |
| MousePheno | abnormal dermal layer morphology | 6.77e-06 | 108 | 35 | 5 | MP:0001243 | |
| MousePheno | hearing/vestibular/ear phenotype | COL2A1 COL4A2 COL4A3 COL4A4 COL9A2 COL9A3 COL11A1 COL11A2 BSN NR2F1 COL1A1 | 7.79e-06 | 905 | 35 | 11 | MP:0005377 |
| MousePheno | abnormal joint mobility | 9.55e-06 | 17 | 35 | 3 | MP:0008069 | |
| MousePheno | abnormal ear morphology | 1.63e-05 | 470 | 35 | 8 | MP:0002102 | |
| MousePheno | albuminuria | 1.77e-05 | 63 | 35 | 4 | MP:0002871 | |
| MousePheno | abnormal limb joint morphology | 3.18e-05 | 25 | 35 | 3 | MP:0030805 | |
| MousePheno | buphthalmos | 3.64e-05 | 4 | 35 | 2 | MP:0009274 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 4.04e-05 | 27 | 35 | 3 | MP:0011409 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 4.04e-05 | 27 | 35 | 3 | MP:0008438 | |
| MousePheno | abnormal joint morphology | 4.78e-05 | 397 | 35 | 7 | MP:0002932 | |
| MousePheno | abnormal glomerular mesangium morphology | 5.26e-05 | 83 | 35 | 4 | MP:0011339 | |
| MousePheno | renal tubule atrophy | 5.57e-05 | 30 | 35 | 3 | MP:0011346 | |
| MousePheno | abnormal compact bone lamellar structure | 6.06e-05 | 5 | 35 | 2 | MP:0010970 | |
| MousePheno | renal glomerular synechia | 6.06e-05 | 5 | 35 | 2 | MP:0011483 | |
| MousePheno | decreased tendon stiffness | 6.06e-05 | 5 | 35 | 2 | MP:0003098 | |
| MousePheno | anterior polar cataract | 6.06e-05 | 5 | 35 | 2 | MP:0010259 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 6.16e-05 | 31 | 35 | 3 | MP:0011349 | |
| MousePheno | abnormal skin tensile strength | 6.79e-05 | 32 | 35 | 3 | MP:0005275 | |
| MousePheno | abnormal auditory brainstem response | 6.95e-05 | 576 | 35 | 8 | MP:0004738 | |
| MousePheno | pale kidney | 7.45e-05 | 33 | 35 | 3 | MP:0004969 | |
| MousePheno | renal cast | 8.16e-05 | 34 | 35 | 3 | MP:0011402 | |
| MousePheno | abnormal hearing electrophysiology | 8.62e-05 | 594 | 35 | 8 | MP:0006335 | |
| MousePheno | micromelia | 9.08e-05 | 6 | 35 | 2 | MP:0008736 | |
| MousePheno | abnormal tendon stiffness | 9.08e-05 | 6 | 35 | 2 | MP:0003097 | |
| MousePheno | polar cataract | 9.08e-05 | 6 | 35 | 2 | MP:0010258 | |
| MousePheno | abnormal tendon physiology | 9.08e-05 | 6 | 35 | 2 | MP:0030802 | |
| MousePheno | sensorineural hearing loss | 1.05e-04 | 37 | 35 | 3 | MP:0004740 | |
| MousePheno | increased large unstained cell number | 1.14e-04 | 38 | 35 | 3 | MP:0012362 | |
| MousePheno | sensorineural hearing impairment | 1.14e-04 | 38 | 35 | 3 | MP:0006329 | |
| MousePheno | podocyte hypertrophy | 1.27e-04 | 7 | 35 | 2 | MP:0011871 | |
| MousePheno | abnormal basement membrane morphology | 1.33e-04 | 40 | 35 | 3 | MP:0004272 | |
| MousePheno | macrophthalmia | 1.69e-04 | 8 | 35 | 2 | MP:0001296 | |
| MousePheno | prominent forehead | 1.69e-04 | 8 | 35 | 2 | MP:0030049 | |
| MousePheno | abnormal blood circulation | COL2A1 COL4A1 COL4A2 COL4A3 COL11A2 ZNF385A TTN COL1A1 COL1A2 | 1.75e-04 | 845 | 35 | 9 | MP:0002128 |
| MousePheno | premature death | COL3A1 COL4A1 COL4A3 COL4A4 COL4A5 PNPLA7 COL17A1 BSN TTN COL1A1 | 1.79e-04 | 1051 | 35 | 10 | MP:0002083 |
| MousePheno | hemorrhage | 1.87e-04 | 664 | 35 | 8 | MP:0001914 | |
| MousePheno | abnormal hyaline cartilage morphology | 2.03e-04 | 46 | 35 | 3 | MP:0006429 | |
| MousePheno | expanded mesangial matrix | 2.03e-04 | 46 | 35 | 3 | MP:0011353 | |
| MousePheno | abnormal glomerular capillary morphology | 2.16e-04 | 47 | 35 | 3 | MP:0011320 | |
| MousePheno | dilated glomerular capillary | 2.17e-04 | 9 | 35 | 2 | MP:0011509 | |
| MousePheno | dermal-epidermal separation | 2.17e-04 | 9 | 35 | 2 | MP:0011160 | |
| MousePheno | aortic dissection | 2.17e-04 | 9 | 35 | 2 | MP:0004044 | |
| MousePheno | abnormal knee joint morphology | 2.17e-04 | 9 | 35 | 2 | MP:0030837 | |
| MousePheno | abnormal aorta morphology | 2.26e-04 | 225 | 35 | 5 | MP:0000272 | |
| MousePheno | abnormal kidney capillary morphology | 2.30e-04 | 48 | 35 | 3 | MP:0011310 | |
| MousePheno | abnormal mesangial matrix morphology | 2.76e-04 | 51 | 35 | 3 | MP:0011338 | |
| MousePheno | abnormal cochlear labyrinth morphology | 2.77e-04 | 235 | 35 | 5 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 2.77e-04 | 235 | 35 | 5 | MP:0003169 | |
| MousePheno | abnormal large unstained cell number | 3.09e-04 | 53 | 35 | 3 | MP:0012360 | |
| MousePheno | kidney atrophy | 3.09e-04 | 53 | 35 | 3 | MP:0004970 | |
| MousePheno | renal interstitial fibrosis | 3.27e-04 | 54 | 35 | 3 | MP:0003215 | |
| MousePheno | decreased collagen level | 3.30e-04 | 11 | 35 | 2 | MP:0020254 | |
| MousePheno | abnormal cochlea morphology | 3.55e-04 | 248 | 35 | 5 | MP:0000031 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 3.96e-04 | 12 | 35 | 2 | MP:0011159 | |
| MousePheno | abnormal muscle physiology | 4.33e-04 | 954 | 35 | 9 | MP:0002106 | |
| MousePheno | abnormal membranous labyrinth morphology | 4.56e-04 | 262 | 35 | 5 | MP:0000035 | |
| MousePheno | dilated capillary | 4.67e-04 | 13 | 35 | 2 | MP:0020326 | |
| MousePheno | total cataract | 4.67e-04 | 13 | 35 | 2 | MP:0010263 | |
| MousePheno | abnormal renal glomerulus morphology | 4.72e-04 | 264 | 35 | 5 | MP:0005325 | |
| MousePheno | increased urine protein level | 5.02e-04 | 149 | 35 | 4 | MP:0002962 | |
| MousePheno | abnormal articular cartilage morphology | 5.44e-04 | 14 | 35 | 2 | MP:0006433 | |
| MousePheno | kidney hemorrhage | 5.44e-04 | 14 | 35 | 2 | MP:0000533 | |
| MousePheno | abnormal kidney interstitium morphology | 6.17e-04 | 67 | 35 | 3 | MP:0011425 | |
| MousePheno | abnormal osteocyte morphology | 6.27e-04 | 15 | 35 | 2 | MP:0008753 | |
| MousePheno | glomerulosclerosis | 6.45e-04 | 68 | 35 | 3 | MP:0005264 | |
| MousePheno | decreased bone trabecula number | 7.02e-04 | 70 | 35 | 3 | MP:0010869 | |
| MousePheno | abnormal artery morphology | 7.02e-04 | 440 | 35 | 6 | MP:0002191 | |
| MousePheno | abnormal collagen level | 7.15e-04 | 16 | 35 | 2 | MP:0020252 | |
| MousePheno | abnormal renal corpuscle morphology | 7.58e-04 | 293 | 35 | 5 | MP:0002827 | |
| MousePheno | abnormal kidney vasculature morphology | 7.93e-04 | 73 | 35 | 3 | MP:0000530 | |
| MousePheno | abnormal forehead shape | 8.09e-04 | 17 | 35 | 2 | MP:0030045 | |
| MousePheno | abnormal urine protein level | 8.24e-04 | 170 | 35 | 4 | MP:0006315 | |
| MousePheno | kidney inflammation | 8.42e-04 | 171 | 35 | 4 | MP:0001859 | |
| MousePheno | abnormal inner ear morphology | 8.81e-04 | 303 | 35 | 5 | MP:0000026 | |
| MousePheno | abnormal systemic artery morphology | 8.94e-04 | 304 | 35 | 5 | MP:0011655 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 9.09e-04 | 18 | 35 | 2 | MP:0030485 | |
| MousePheno | renal fibrosis | 9.62e-04 | 78 | 35 | 3 | MP:0003985 | |
| MousePheno | small vertebral body | 1.01e-03 | 19 | 35 | 2 | MP:0004670 | |
| MousePheno | glomerular crescent | 1.01e-03 | 19 | 35 | 2 | MP:0011506 | |
| MousePheno | renal/urinary system inflammation | 1.02e-03 | 180 | 35 | 4 | MP:0011762 | |
| MousePheno | increased inflammatory response | COL3A1 COL4A1 COL4A3 COL4A4 COL4A5 COL11A1 COL17A1 TTN COL1A1 | 1.04e-03 | 1077 | 35 | 9 | MP:0001846 |
| MousePheno | abnormal forelimb morphology | 1.06e-03 | 182 | 35 | 4 | MP:0000550 | |
| MousePheno | postnatal lethality | COL2A1 COL3A1 COL4A1 COL4A2 COL7A1 ZNF385A COL17A1 TCF20 COL1A1 | 1.09e-03 | 1084 | 35 | 9 | MP:0002082 |
| MousePheno | lens vacuoles | 1.12e-03 | 20 | 35 | 2 | MP:0011697 | |
| MousePheno | abnormal hindlimb joint morphology | 1.12e-03 | 20 | 35 | 2 | MP:0030808 | |
| MousePheno | abnormal lens capsule morphology | 1.12e-03 | 20 | 35 | 2 | MP:0003236 | |
| MousePheno | abnormal chondrocyte morphology | 1.15e-03 | 83 | 35 | 3 | MP:0000166 | |
| MousePheno | postnatal lethality, incomplete penetrance | 1.16e-03 | 669 | 35 | 7 | MP:0011086 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 MBL2 COL1A1 COL1A2 | 5.56e-40 | 85 | 40 | 21 | PF01391 |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 MBL2 COL1A1 COL1A2 | 5.56e-40 | 85 | 40 | 21 | IPR008160 |
| Domain | NC1_FIB | 3.44e-20 | 11 | 40 | 8 | PS51461 | |
| Domain | Fib_collagen_C | 3.44e-20 | 11 | 40 | 8 | IPR000885 | |
| Domain | Fib_collagen_C | 3.44e-20 | 11 | 40 | 8 | PD002078 | |
| Domain | COLFI | 3.44e-20 | 11 | 40 | 8 | SM00038 | |
| Domain | COLFI | 3.44e-20 | 11 | 40 | 8 | PF01410 | |
| Domain | C4 | 2.08e-13 | 6 | 40 | 5 | SM00111 | |
| Domain | - | 2.08e-13 | 6 | 40 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.08e-13 | 6 | 40 | 5 | IPR001442 | |
| Domain | NC1_IV | 2.08e-13 | 6 | 40 | 5 | PS51403 | |
| Domain | C4 | 2.08e-13 | 6 | 40 | 5 | PF01413 | |
| Domain | CTDL_fold | 1.01e-07 | 107 | 40 | 6 | IPR016187 | |
| Domain | TSPN | 1.55e-07 | 23 | 40 | 4 | SM00210 | |
| Domain | Laminin_G_2 | 1.56e-06 | 40 | 40 | 4 | PF02210 | |
| Domain | LamG | 2.30e-06 | 44 | 40 | 4 | SM00282 | |
| Domain | Laminin_G | 7.04e-06 | 58 | 40 | 4 | IPR001791 | |
| Domain | c-SKI_SMAD4-bd_dom | 2.68e-05 | 4 | 40 | 2 | IPR014890 | |
| Domain | Tscrpt_reg_SKI_SnoN | 2.68e-05 | 4 | 40 | 2 | IPR023216 | |
| Domain | c-SKI_SMAD_bind | 2.68e-05 | 4 | 40 | 2 | PF08782 | |
| Domain | c-SKI_SMAD_bind | 2.68e-05 | 4 | 40 | 2 | SM01046 | |
| Domain | VWC | 2.87e-05 | 28 | 40 | 3 | PF00093 | |
| Domain | - | 4.99e-05 | 95 | 40 | 4 | 2.60.120.200 | |
| Domain | VWFC_1 | 6.19e-05 | 36 | 40 | 3 | PS01208 | |
| Domain | VWC | 7.29e-05 | 38 | 40 | 3 | SM00214 | |
| Domain | VWFC_2 | 7.29e-05 | 38 | 40 | 3 | PS50184 | |
| Domain | Ski_Sno | 9.33e-05 | 7 | 40 | 2 | PF02437 | |
| Domain | - | 9.33e-05 | 7 | 40 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 9.33e-05 | 7 | 40 | 2 | IPR003380 | |
| Domain | VWF_dom | 9.86e-05 | 42 | 40 | 3 | IPR001007 | |
| Domain | VWA | 2.33e-04 | 56 | 40 | 3 | PF00092 | |
| Domain | DNA-bd_dom_put | 2.43e-04 | 11 | 40 | 2 | IPR009061 | |
| Domain | SAND_dom-like | 2.91e-04 | 12 | 40 | 2 | IPR010919 | |
| Domain | - | 2.91e-04 | 12 | 40 | 2 | 3.10.390.10 | |
| Domain | - | 5.31e-04 | 74 | 40 | 3 | 3.40.50.410 | |
| Domain | VWFA | 7.17e-04 | 82 | 40 | 3 | PS50234 | |
| Domain | VWA | 7.69e-04 | 84 | 40 | 3 | SM00327 | |
| Domain | ConA-like_dom | 1.21e-03 | 219 | 40 | 4 | IPR013320 | |
| Domain | VWF_A | 1.24e-03 | 99 | 40 | 3 | IPR002035 | |
| Domain | ZnF_U1 | 1.75e-03 | 29 | 40 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.75e-03 | 29 | 40 | 2 | IPR003604 | |
| Domain | Znf_FYVE_PHD | 3.81e-03 | 147 | 40 | 3 | IPR011011 | |
| Domain | fn3 | 5.00e-03 | 162 | 40 | 3 | PF00041 | |
| Domain | FN3 | 7.22e-03 | 185 | 40 | 3 | SM00060 | |
| Domain | FN3 | 8.81e-03 | 199 | 40 | 3 | PS50853 | |
| Domain | SAM_1 | 9.32e-03 | 68 | 40 | 2 | PF00536 | |
| Domain | FN3_dom | 1.01e-02 | 209 | 40 | 3 | IPR003961 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 9.43e-45 | 41 | 34 | 20 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 6.15e-44 | 44 | 34 | 20 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.14e-40 | 61 | 34 | 20 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 6.72e-40 | 64 | 34 | 20 | M26953 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 1.98e-39 | 67 | 34 | 20 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 3.69e-38 | 76 | 34 | 20 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 9.54e-38 | 61 | 34 | 19 | M27103 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 5.15e-37 | 50 | 34 | 18 | MM14796 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 1.70e-36 | 90 | 34 | 20 | M631 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.83e-32 | 46 | 34 | 16 | M198 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.64e-32 | 140 | 34 | 20 | M587 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 2.71e-31 | 53 | 34 | 16 | MM14566 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 5.14e-31 | 20 | 34 | 13 | MM15061 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL6A6 COL1A1 COL1A2 | 7.22e-30 | 85 | 34 | 17 | M16441 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.20e-28 | 74 | 34 | 16 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL6A6 COL1A1 COL1A2 | 1.93e-28 | 76 | 34 | 16 | MM14867 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 2.26e-27 | 32 | 34 | 13 | MM14924 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 9.38e-27 | 258 | 34 | 20 | MM14572 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 3.50e-26 | 38 | 34 | 13 | MM14969 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 COL1A1 COL1A2 | 3.73e-26 | 76 | 34 | 15 | M27219 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 1.64e-25 | 42 | 34 | 13 | M7169 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.05e-25 | 300 | 34 | 20 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 2.19e-25 | 114 | 34 | 16 | MM14571 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 1.54e-23 | 57 | 34 | 13 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 1.98e-23 | 58 | 34 | 13 | M2049 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 2.54e-23 | 59 | 34 | 13 | M27218 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 6.54e-23 | 63 | 34 | 13 | M11187 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL1A1 COL1A2 | 1.27e-22 | 66 | 34 | 13 | M18 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL6A1 COL5A3 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 3.79e-21 | 84 | 34 | 13 | M7098 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL11A1 COL11A2 COL6A6 EPN1 COL1A1 COL1A2 | 3.12e-19 | 418 | 34 | 18 | MM15587 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.99e-18 | 15 | 34 | 8 | M27161 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL3A1 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 COL1A1 COL1A2 | 7.53e-18 | 47 | 34 | 10 | MM14925 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL11A1 COL11A2 COL6A6 EPN1 COL1A1 COL1A2 | 2.29e-17 | 532 | 34 | 18 | M27870 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.49e-17 | 19 | 34 | 8 | MM15512 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 3.93e-16 | 261 | 34 | 14 | MM15676 |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL6A1 COL5A3 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 4.27e-16 | 199 | 34 | 13 | M7253 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.66e-15 | 30 | 34 | 8 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.66e-15 | 30 | 34 | 8 | MM15517 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.67e-15 | 18 | 34 | 7 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.67e-15 | 18 | 34 | 7 | MM14882 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.26e-14 | 41 | 34 | 8 | M27778 | |
| Pathway | WP_FOCAL_ADHESION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 3.65e-13 | 187 | 34 | 11 | MM15913 |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.78e-12 | 67 | 34 | 8 | MM15345 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 3.19e-12 | 502 | 34 | 14 | MM14537 |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 7.45e-12 | 43 | 34 | 7 | M39565 | |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL6A1 COL9A2 COL9A3 COL6A6 COL1A1 COL1A2 | 1.05e-11 | 339 | 34 | 12 | M39736 |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.09e-11 | 79 | 34 | 8 | M27643 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.50e-11 | 10 | 34 | 5 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.50e-11 | 10 | 34 | 5 | MM1560 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 1.98e-11 | 575 | 34 | 14 | M29853 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.74e-11 | 11 | 34 | 5 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.70e-11 | 12 | 34 | 5 | MM1526 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 6.71e-11 | 302 | 34 | 11 | M39719 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.04e-11 | 30 | 34 | 6 | M27216 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.62e-11 | 13 | 34 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.62e-11 | 13 | 34 | 5 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.18e-10 | 14 | 34 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.18e-10 | 14 | 34 | 5 | M6487 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.52e-10 | 326 | 34 | 11 | MM15917 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.77e-10 | 15 | 34 | 5 | MM14922 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 6.81e-10 | 19 | 34 | 5 | M27221 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 7.07e-10 | 43 | 34 | 6 | M53 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 9.07e-10 | 20 | 34 | 5 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.96e-09 | 23 | 34 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.96e-09 | 23 | 34 | 5 | MM1427 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.67e-09 | 27 | 34 | 5 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 5.67e-09 | 28 | 34 | 5 | MM15957 | |
| Pathway | WP_FOCAL_ADHESION | 3.92e-07 | 199 | 34 | 7 | M39402 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 COL4A1 EPHB4 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL9A2 COL9A3 COL6A6 | 2.29e-06 | 1432 | 34 | 14 | M509 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.14e-06 | 96 | 34 | 5 | M39834 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 3.47e-06 | 98 | 34 | 5 | M27152 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 1.02e-05 | 18 | 34 | 3 | M39421 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.66e-05 | 135 | 34 | 5 | MM14781 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.89e-05 | 161 | 34 | 5 | M39770 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.98e-05 | 30 | 34 | 3 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.98e-05 | 30 | 34 | 3 | M39641 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 8.42e-05 | 6 | 34 | 2 | M39872 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 8.55e-05 | 190 | 34 | 5 | M8240 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.18e-04 | 7 | 34 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.57e-04 | 8 | 34 | 2 | M48236 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.70e-04 | 45 | 34 | 3 | M39864 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.33e-04 | 50 | 34 | 3 | M48087 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 3.67e-04 | 12 | 34 | 2 | MM15093 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 3.67e-04 | 12 | 34 | 2 | MM15452 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 3.67e-04 | 12 | 34 | 2 | M27352 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 6.02e-04 | 69 | 34 | 3 | M48052 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 6.63e-04 | 16 | 34 | 2 | M9450 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.82e-04 | 72 | 34 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 7.10e-04 | 73 | 34 | 3 | MM15906 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 9.41e-04 | 19 | 34 | 2 | M48230 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.07e-03 | 84 | 34 | 3 | M3228 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 1.47e-03 | 725 | 34 | 7 | M27507 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.64e-03 | 25 | 34 | 2 | M274 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 2.05e-03 | 28 | 34 | 2 | M42541 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.84e-03 | 33 | 34 | 2 | M39875 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 2.84e-03 | 33 | 34 | 2 | M39870 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.20e-03 | 35 | 34 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.20e-03 | 35 | 34 | 2 | M773 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.76e-03 | 38 | 34 | 2 | MM15456 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.78e-03 | 439 | 34 | 5 | M42563 | |
| Pubmed | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 3.07e-29 | 175 | 40 | 17 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A3 COL7A1 COL11A2 COL17A1 COL1A1 COL1A2 | 5.53e-27 | 62 | 40 | 13 | 28344315 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL11A2 COL6A6 COL1A1 COL1A2 | 1.14e-26 | 135 | 40 | 15 | 28675934 |
| Pubmed | COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL17A1 COL6A6 COL1A1 COL1A2 | 8.09e-26 | 153 | 40 | 15 | 25037231 | |
| Pubmed | 6.51e-23 | 10 | 40 | 8 | 2446864 | ||
| Pubmed | COL2A1 COL3A1 COL5A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 2.69e-21 | 25 | 40 | 9 | 19180518 | |
| Pubmed | COL3A1 COL4A1 COL23A1 COL4A2 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A3 COL1A1 COL1A2 | 4.82e-21 | 167 | 40 | 13 | 22159717 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 9.28e-21 | 15 | 40 | 8 | 9832566 | |
| Pubmed | 5.49e-20 | 9 | 40 | 7 | 9878537 | ||
| Pubmed | 5.49e-20 | 9 | 40 | 7 | 8900172 | ||
| Pubmed | 1.09e-19 | 19 | 40 | 8 | 15689378 | ||
| Pubmed | 1.83e-19 | 10 | 40 | 7 | 9415455 | ||
| Pubmed | COL2A1 COL23A1 COL4A3 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL11A1 COL11A2 COL17A1 COL1A2 | 8.24e-18 | 210 | 40 | 12 | 16537572 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 COL1A1 COL1A2 | 1.40e-17 | 97 | 40 | 10 | 27559042 |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 4.37e-17 | 8 | 40 | 6 | 20059976 | |
| Pubmed | 4.37e-17 | 8 | 40 | 6 | 3997552 | ||
| Pubmed | 4.37e-17 | 8 | 40 | 6 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 4.37e-17 | 8 | 40 | 6 | 11867580 | |
| Pubmed | 4.37e-17 | 8 | 40 | 6 | 9164858 | ||
| Pubmed | 4.37e-17 | 8 | 40 | 6 | 10382266 | ||
| Pubmed | 8.70e-17 | 39 | 40 | 8 | 33580754 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL11A1 COL1A1 COL1A2 | 5.77e-16 | 86 | 40 | 9 | 28327460 |
| Pubmed | 7.52e-16 | 50 | 40 | 8 | 23658023 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.33e-15 | 27 | 40 | 7 | 12192060 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.44e-15 | 12 | 40 | 6 | 12180907 | |
| Pubmed | 1.55e-15 | 5 | 40 | 5 | 9409248 | ||
| Pubmed | 1.55e-15 | 5 | 40 | 5 | 15365990 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 9.31e-15 | 6 | 40 | 5 | 9506531 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 7495302 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 9.31e-15 | 6 | 40 | 5 | 17029294 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 9.31e-15 | 6 | 40 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 9.31e-15 | 6 | 40 | 5 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 9.31e-15 | 6 | 40 | 5 | 6389236 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 12225806 | ||
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 20301479 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 9.31e-15 | 6 | 40 | 5 | 10534397 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 21467034 | ||
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 10722718 | ||
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 9101290 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 9.31e-15 | 6 | 40 | 5 | 8563024 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 9.31e-15 | 6 | 40 | 5 | 9673377 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 15922184 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 9.31e-15 | 6 | 40 | 5 | 3571333 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 9.31e-15 | 6 | 40 | 5 | 19275937 | |
| Pubmed | 9.31e-15 | 6 | 40 | 5 | 6988303 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 MBL2 COL1A1 COL1A2 | 1.11e-14 | 186 | 40 | 10 | 20673868 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 MBL2 COL1A1 COL1A2 | 1.11e-14 | 186 | 40 | 10 | 20452482 | |
| Pubmed | 1.24e-14 | 16 | 40 | 6 | 17881772 | ||
| Pubmed | 3.25e-14 | 7 | 40 | 5 | 10639489 | ||
| Pubmed | 3.25e-14 | 7 | 40 | 5 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 3.25e-14 | 7 | 40 | 5 | 8006028 | |
| Pubmed | 3.25e-14 | 7 | 40 | 5 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 3.25e-14 | 7 | 40 | 5 | 10716744 | |
| Pubmed | 3.25e-14 | 7 | 40 | 5 | 1724753 | ||
| Pubmed | 3.25e-14 | 7 | 40 | 5 | 7521231 | ||
| Pubmed | 8.37e-14 | 21 | 40 | 6 | 27856617 | ||
| Pubmed | 8.67e-14 | 8 | 40 | 5 | 29422532 | ||
| Pubmed | 8.67e-14 | 8 | 40 | 5 | 18816857 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 8.67e-14 | 8 | 40 | 5 | 10970885 | |
| Pubmed | 1.95e-13 | 9 | 40 | 5 | 8562707 | ||
| Pubmed | 1.95e-13 | 9 | 40 | 5 | 12101409 | ||
| Pubmed | 2.07e-13 | 24 | 40 | 6 | 25344368 | ||
| Pubmed | 3.90e-13 | 10 | 40 | 5 | 9136074 | ||
| Pubmed | 7.14e-13 | 11 | 40 | 5 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 7.14e-13 | 11 | 40 | 5 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 7.14e-13 | 11 | 40 | 5 | 9731539 | |
| Pubmed | 1.22e-12 | 12 | 40 | 5 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.22e-12 | 12 | 40 | 5 | 15837576 | |
| Pubmed | 1.22e-12 | 12 | 40 | 5 | 16024816 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 1.50e-12 | 4 | 40 | 4 | 7827955 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 1.50e-12 | 4 | 40 | 4 | 17683922 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.98e-12 | 13 | 40 | 5 | 9833687 | |
| Pubmed | 3.08e-12 | 14 | 40 | 5 | 12878203 | ||
| Pubmed | 4.20e-12 | 38 | 40 | 6 | 25572963 | ||
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 4.62e-12 | 15 | 40 | 5 | 10579729 | |
| Pubmed | 4.62e-12 | 15 | 40 | 5 | 10625553 | ||
| Pubmed | 4.62e-12 | 15 | 40 | 5 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 4.62e-12 | 15 | 40 | 5 | 10706142 | |
| Pubmed | 5.45e-12 | 146 | 40 | 8 | 27068509 | ||
| Pubmed | 6.72e-12 | 16 | 40 | 5 | 15878328 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 7.49e-12 | 5 | 40 | 4 | 14758483 | |
| Pubmed | Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. | 7.49e-12 | 5 | 40 | 4 | 16133074 | |
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.23e-11 | 45 | 40 | 6 | 34248495 | |
| Pubmed | 1.32e-11 | 18 | 40 | 5 | 9160753 | ||
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 2.25e-11 | 6 | 40 | 4 | 12883905 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 16192629 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 8305476 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 17876790 | ||
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 2.25e-11 | 6 | 40 | 4 | 22492985 | |
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 9426396 | ||
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 23273220 | ||
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 5.23e-11 | 7 | 40 | 4 | 9334230 | |
| Pubmed | 1.00e-10 | 26 | 40 | 5 | 24742657 | ||
| Pubmed | Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. | 1.00e-10 | 26 | 40 | 5 | 21367821 | |
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 15872058 | ||
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 1383086 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 1.05e-10 | 8 | 40 | 4 | 24563484 | |
| Interaction | MMP9 interactions | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL1A1 COL1A2 | 6.40e-17 | 67 | 40 | 10 | int:MMP9 |
| Interaction | LAIR2 interactions | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL6A1 COL17A1 COL1A1 | 3.52e-16 | 49 | 40 | 9 | int:LAIR2 |
| Interaction | MAG interactions | 4.75e-16 | 29 | 40 | 8 | int:MAG | |
| Interaction | DCN interactions | 1.57e-14 | 43 | 40 | 8 | int:DCN | |
| Interaction | CD93 interactions | 2.33e-14 | 45 | 40 | 8 | int:CD93 | |
| Interaction | TGFBI interactions | 3.26e-14 | 25 | 40 | 7 | int:TGFBI | |
| Interaction | PDGFA interactions | 2.26e-13 | 32 | 40 | 7 | int:PDGFA | |
| Interaction | COLGALT2 interactions | 6.85e-13 | 67 | 40 | 8 | int:COLGALT2 | |
| Interaction | MMP2 interactions | 5.96e-12 | 87 | 40 | 8 | int:MMP2 | |
| Interaction | BGN interactions | 2.37e-11 | 30 | 40 | 6 | int:BGN | |
| Interaction | THBS1 interactions | 1.29e-10 | 127 | 40 | 8 | int:THBS1 | |
| Interaction | HABP2 interactions | 2.00e-10 | 18 | 40 | 5 | int:HABP2 | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL23A1 COL4A2 COL4A4 COL4A5 COL5A1 COL6A1 COL9A3 COL1A1 | 2.02e-10 | 292 | 40 | 10 | int:PLOD1 |
| Interaction | OSM interactions | 3.61e-10 | 20 | 40 | 5 | int:OSM | |
| Interaction | PDGFB interactions | 3.94e-10 | 88 | 40 | 7 | int:PDGFB | |
| Interaction | C1QTNF1 interactions | 4.18e-10 | 47 | 40 | 6 | int:C1QTNF1 | |
| Interaction | COL2A1 interactions | 2.85e-09 | 64 | 40 | 6 | int:COL2A1 | |
| Interaction | SPARC interactions | 3.13e-09 | 65 | 40 | 6 | int:SPARC | |
| Interaction | COL1A2 interactions | 9.55e-09 | 78 | 40 | 6 | int:COL1A2 | |
| Interaction | COL8A2 interactions | 1.92e-08 | 42 | 40 | 5 | int:COL8A2 | |
| Interaction | FGF7 interactions | 2.38e-08 | 16 | 40 | 4 | int:FGF7 | |
| Interaction | FN1 interactions | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL7A1 RBM12 EPN1 TTN COL1A1 COL1A2 | 5.36e-08 | 848 | 40 | 12 | int:FN1 |
| Interaction | PLOD3 interactions | 6.57e-08 | 183 | 40 | 7 | int:PLOD3 | |
| Interaction | SERPINE2 interactions | 8.43e-08 | 56 | 40 | 5 | int:SERPINE2 | |
| Interaction | MATN2 interactions | 8.93e-08 | 113 | 40 | 6 | int:MATN2 | |
| Interaction | FBLN2 interactions | 1.94e-07 | 66 | 40 | 5 | int:FBLN2 | |
| Interaction | ANTXR2 interactions | 3.05e-07 | 29 | 40 | 4 | int:ANTXR2 | |
| Interaction | C1QTNF9 interactions | 8.38e-07 | 37 | 40 | 4 | int:C1QTNF9 | |
| Interaction | COL5A3 interactions | 8.61e-07 | 10 | 40 | 3 | int:COL5A3 | |
| Interaction | C1QC interactions | 1.41e-06 | 42 | 40 | 4 | int:C1QC | |
| Interaction | COL9A1 interactions | 2.04e-06 | 13 | 40 | 3 | int:COL9A1 | |
| Interaction | COL4A1 interactions | 2.43e-06 | 48 | 40 | 4 | int:COL4A1 | |
| Interaction | SAA1 interactions | 3.92e-06 | 54 | 40 | 4 | int:SAA1 | |
| Interaction | C1QTNF2 interactions | 6.83e-06 | 62 | 40 | 4 | int:C1QTNF2 | |
| Interaction | COL5A1 interactions | 8.25e-06 | 65 | 40 | 4 | int:COL5A1 | |
| Interaction | COL4A2 interactions | 1.46e-05 | 75 | 40 | 4 | int:COL4A2 | |
| Interaction | COL7A1 interactions | 1.62e-05 | 25 | 40 | 3 | int:COL7A1 | |
| Interaction | TIMP2 interactions | 1.66e-05 | 277 | 40 | 6 | int:TIMP2 | |
| Interaction | COL5A2 interactions | 2.55e-05 | 29 | 40 | 3 | int:COL5A2 | |
| Interaction | VWF interactions | 3.45e-05 | 32 | 40 | 3 | int:VWF | |
| Interaction | TGM2 interactions | 9.75e-05 | 235 | 40 | 5 | int:TGM2 | |
| Interaction | BMP3 interactions | 1.07e-04 | 8 | 40 | 2 | int:BMP3 | |
| Interaction | SMAD7 interactions | 1.15e-04 | 127 | 40 | 4 | int:SMAD7 | |
| Interaction | NID1 interactions | 1.18e-04 | 48 | 40 | 3 | int:NID1 | |
| Interaction | DDR1 interactions | 1.26e-04 | 130 | 40 | 4 | int:DDR1 | |
| Interaction | ADAMTS5 interactions | 1.37e-04 | 9 | 40 | 2 | int:ADAMTS5 | |
| Interaction | PAX3 interactions | 1.50e-04 | 52 | 40 | 3 | int:PAX3 | |
| Interaction | HTRA1 interactions | 1.67e-04 | 54 | 40 | 3 | int:HTRA1 | |
| Interaction | COL9A3 interactions | 1.71e-04 | 10 | 40 | 2 | int:COL9A3 | |
| Interaction | PCOLCE interactions | 2.09e-04 | 11 | 40 | 2 | int:PCOLCE | |
| Interaction | TMEM44 interactions | 3.97e-04 | 15 | 40 | 2 | int:TMEM44 | |
| Interaction | ANXA7 interactions | 4.75e-04 | 184 | 40 | 4 | int:ANXA7 | |
| Interaction | COL9A2 interactions | 5.13e-04 | 17 | 40 | 2 | int:COL9A2 | |
| Interaction | COL16A1 interactions | 5.76e-04 | 18 | 40 | 2 | int:COL16A1 | |
| Interaction | FKBP9 interactions | 6.84e-04 | 87 | 40 | 3 | int:FKBP9 | |
| Interaction | CBLL2 interactions | 7.14e-04 | 20 | 40 | 2 | int:CBLL2 | |
| Interaction | VHL interactions | 7.77e-04 | 561 | 40 | 6 | int:VHL | |
| Interaction | TLE3 interactions | 8.47e-04 | 376 | 40 | 5 | int:TLE3 | |
| Interaction | MPPED2 interactions | 8.65e-04 | 22 | 40 | 2 | int:MPPED2 | |
| Interaction | COL18A1 interactions | 9.67e-04 | 98 | 40 | 3 | int:COL18A1 | |
| Interaction | NFIX interactions | 1.04e-03 | 227 | 40 | 4 | int:NFIX | |
| Interaction | SMAD1 interactions | 1.34e-03 | 243 | 40 | 4 | int:SMAD1 | |
| Interaction | BMP1 interactions | 1.39e-03 | 111 | 40 | 3 | int:BMP1 | |
| Interaction | COL11A1 interactions | 1.51e-03 | 29 | 40 | 2 | int:COL11A1 | |
| Interaction | GIPC2 interactions | 1.61e-03 | 30 | 40 | 2 | int:GIPC2 | |
| Interaction | PRNP interactions | 1.72e-03 | 1158 | 40 | 8 | int:PRNP | |
| Interaction | LUM interactions | 1.83e-03 | 32 | 40 | 2 | int:LUM | |
| Interaction | PRELP interactions | 1.83e-03 | 32 | 40 | 2 | int:PRELP | |
| Interaction | COLQ interactions | 1.95e-03 | 33 | 40 | 2 | int:COLQ | |
| Interaction | COL1A1 interactions | 2.08e-03 | 128 | 40 | 3 | int:COL1A1 | |
| Interaction | COL8A1 interactions | 2.22e-03 | 131 | 40 | 3 | int:COL8A1 | |
| Interaction | CAMKMT interactions | 2.32e-03 | 36 | 40 | 2 | int:CAMKMT | |
| Cytoband | 2q31 | 5.74e-05 | 13 | 40 | 2 | 2q31 | |
| Cytoband | 13q34 | 1.03e-03 | 54 | 40 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 2.52e-03 | 85 | 40 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 2.70e-03 | 88 | 40 | 2 | chr13q34 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 3.15e-45 | 46 | 35 | 20 | 490 |
| GeneFamily | SKI transcriptional corepressors | 2.18e-05 | 4 | 35 | 2 | 748 | |
| GeneFamily | Collagens|Collagen proteoglycans | 3.63e-05 | 5 | 35 | 2 | 575 | |
| GeneFamily | Fibronectin type III domain containing | 3.62e-03 | 160 | 35 | 3 | 555 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 1.36e-47 | 43 | 40 | 20 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 2.50e-47 | 44 | 40 | 20 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 1.02e-29 | 270 | 40 | 20 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 COL1A1 COL1A2 | 1.48e-29 | 275 | 40 | 20 | M5884 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 MBL2 COL1A1 COL1A2 | 1.03e-19 | 1008 | 40 | 21 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL6A6 MBL2 COL1A1 COL1A2 | 1.48e-19 | 1026 | 40 | 21 | M5889 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.67e-15 | 23 | 40 | 7 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.99e-13 | 40 | 40 | 7 | M5887 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.95e-12 | 29 | 40 | 6 | MM17055 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL3A1 COL4A1 COL4A2 COL5A1 COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 1.63e-11 | 200 | 40 | 9 | M5930 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.85e-11 | 74 | 40 | 7 | M13547 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.90e-11 | 17 | 40 | 5 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.90e-11 | 17 | 40 | 5 | MM1297 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 4.89e-10 | 194 | 40 | 8 | M39122 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 6.60e-10 | 65 | 40 | 6 | M39309 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 8.19e-10 | 126 | 40 | 7 | M39132 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.14e-09 | 71 | 40 | 6 | M3955 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.47e-09 | 137 | 40 | 7 | M40313 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.55e-09 | 81 | 40 | 6 | M39253 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 5.17e-09 | 91 | 40 | 6 | M40180 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 6.64e-09 | 44 | 40 | 5 | M18274 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 9.35e-09 | 47 | 40 | 5 | M7585 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 NR2F1 COL1A1 COL1A2 | 1.34e-08 | 767 | 40 | 11 | M39209 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 2.74e-08 | 120 | 40 | 6 | M42505 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 3.33e-08 | 22 | 40 | 4 | M40074 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 4.56e-08 | 64 | 40 | 5 | M2572 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.17e-08 | 352 | 40 | 8 | M17471 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL5A3 COL1A1 COL1A2 | 5.48e-08 | 505 | 40 | 9 | M39167 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.20e-08 | 68 | 40 | 5 | M1373 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 6.20e-08 | 68 | 40 | 5 | M45669 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 6.56e-08 | 6 | 40 | 3 | M48000 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.68e-08 | 69 | 40 | 5 | M10165 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 8.29e-08 | 72 | 40 | 5 | MM1131 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.03e-07 | 385 | 40 | 8 | M39264 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.33e-07 | 79 | 40 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.41e-07 | 80 | 40 | 5 | MM1285 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.70e-07 | 163 | 40 | 6 | M2769 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.70e-07 | 83 | 40 | 5 | M2448 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.84e-07 | 33 | 40 | 4 | M9167 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 2.35e-07 | 35 | 40 | 4 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.35e-07 | 35 | 40 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.64e-07 | 36 | 40 | 4 | MM1212 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 4.08e-07 | 40 | 40 | 4 | M1574 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 4.11e-07 | 99 | 40 | 5 | M39152 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 4.46e-07 | 192 | 40 | 6 | M42501 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 4.59e-07 | 316 | 40 | 7 | M2293 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 4.79e-07 | 318 | 40 | 7 | M41707 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 5.32e-07 | 323 | 40 | 7 | MM1066 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 5.39e-07 | 11 | 40 | 3 | M47997 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 5.66e-07 | 200 | 40 | 6 | M6263 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 6.62e-07 | 45 | 40 | 4 | M1605 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 7.07e-07 | 337 | 40 | 7 | MM16606 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 7.17e-07 | 12 | 40 | 3 | MM3646 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 7.24e-07 | 46 | 40 | 4 | MM670 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 7.24e-07 | 46 | 40 | 4 | MM1187 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 7.24e-07 | 46 | 40 | 4 | MM544 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 7.27e-07 | 111 | 40 | 5 | M45685 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 7.74e-07 | 211 | 40 | 6 | M12225 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 7.91e-07 | 47 | 40 | 4 | M1399 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 9.44e-07 | 117 | 40 | 5 | M39300 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 1.02e-06 | 50 | 40 | 4 | MM403 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.29e-06 | 369 | 40 | 7 | MM16610 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.45e-06 | 235 | 40 | 6 | M5311 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.48e-06 | 15 | 40 | 3 | MM402 | |
| Coexpression | DEMAGALHAES_AGING_DN | 1.82e-06 | 16 | 40 | 3 | M2145 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.86e-06 | 58 | 40 | 4 | M178 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.37e-06 | 141 | 40 | 5 | M10381 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.43e-06 | 62 | 40 | 4 | M16774 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 2.43e-06 | 257 | 40 | 6 | M13867 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.82e-06 | 146 | 40 | 5 | MM973 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.82e-06 | 146 | 40 | 5 | M40222 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 3.10e-06 | 268 | 40 | 6 | M45796 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 3.11e-06 | 149 | 40 | 5 | M45703 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 3.14e-06 | 19 | 40 | 3 | M15125 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 4.30e-06 | 21 | 40 | 3 | M4767 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.44e-06 | 72 | 40 | 4 | M9908 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 4.68e-06 | 162 | 40 | 5 | M45037 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 4.95e-06 | 74 | 40 | 4 | M4479 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 5.23e-06 | 75 | 40 | 4 | MM1084 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL11A1 COL11A2 TTN COL1A1 COL1A2 | 5.81e-06 | 1136 | 40 | 10 | M2247 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 6.26e-06 | 303 | 40 | 6 | M39040 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 6.50e-06 | 305 | 40 | 6 | M19875 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.21e-06 | 479 | 40 | 7 | M2573 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 7.35e-06 | 681 | 40 | 8 | M39175 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.61e-06 | 483 | 40 | 7 | MM1082 | |
| Coexpression | ZHU_CMV_24_HR_DN | 8.21e-06 | 84 | 40 | 4 | M4065 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 8.94e-06 | 185 | 40 | 5 | M42503 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 9.02e-06 | 86 | 40 | 4 | M2259 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL11A1 COL11A2 TTN COL1A1 COL1A2 | 9.26e-06 | 1198 | 40 | 10 | MM1062 |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 1.17e-05 | 29 | 40 | 3 | M7581 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 1.37e-05 | 202 | 40 | 5 | M38982 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 1.37e-05 | 202 | 40 | 5 | M11840 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 1.44e-05 | 31 | 40 | 3 | M18395 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 1.58e-05 | 99 | 40 | 4 | M40255 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.77e-05 | 102 | 40 | 4 | MM1064 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.91e-05 | 34 | 40 | 3 | M1955 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 1.99e-05 | 105 | 40 | 4 | M12602 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN | 2.08e-05 | 35 | 40 | 3 | M40938 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 2.25e-05 | 224 | 40 | 5 | M9893 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 2.26e-05 | 5 | 40 | 2 | M47996 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 SHANK1 COL3A1 COL4A1 COL4A2 COL5A1 COL5A3 COL9A2 COL11A1 SPOCD1 NR2F1 COL1A1 COL1A2 | 2.72e-08 | 1094 | 38 | 13 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL5A3 COL11A1 COL11A2 SPOCD1 NR2F1 COL1A1 COL1A2 | 5.60e-08 | 951 | 38 | 12 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | COL2A1 COL3A1 COL6A1 COL9A2 COL9A3 COL17A1 TTN NR2F1 COL1A1 COL1A2 | 5.87e-08 | 589 | 38 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.15e-07 | 66 | 38 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.79e-07 | 72 | 38 | 5 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 2.06e-07 | 74 | 38 | 5 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 7.99e-07 | 97 | 38 | 5 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL23A1 COL4A4 COL4A5 COL5A1 COL6A1 COL9A2 COL11A1 NR2F1 COL1A1 COL1A2 | 8.81e-07 | 790 | 38 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL6A1 COL9A2 COL9A3 COL17A1 TTN COL1A1 COL1A2 | 9.33e-07 | 607 | 38 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL23A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL11A1 TTN COL1A1 COL1A2 | 9.54e-07 | 797 | 38 | 10 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 9.84e-07 | 445 | 38 | 8 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.12e-06 | 453 | 38 | 8 | GSM777067_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.27e-06 | 197 | 38 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 COL6A1 COL9A2 COL9A3 COL17A1 TTN NR2F1 COL1A1 COL1A2 | 1.44e-06 | 834 | 38 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.45e-06 | 234 | 38 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL23A1 COL4A2 COL4A5 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 ZNF608 | 3.57e-06 | 1153 | 38 | 11 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.72e-06 | 371 | 38 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 COL3A1 COL6A1 COL9A2 COL9A3 COL17A1 TTN COL1A1 COL1A2 | 4.96e-06 | 744 | 38 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 5.42e-06 | 143 | 38 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 5.61e-06 | 395 | 38 | 7 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | BM Top 100 - cervix | 5.80e-06 | 66 | 38 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.80e-06 | 66 | 38 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.93e-06 | 567 | 38 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL5A3 COL11A1 COL6A6 SPOCD1 NR2F1 COL1A1 COL1A2 | 6.13e-06 | 981 | 38 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 6.50e-06 | 404 | 38 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 6.93e-06 | 69 | 38 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 7.34e-06 | 70 | 38 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL23A1 CRYBB1 COL7A1 COL9A2 COL9A3 INAFM2 ZNF385A COL17A1 ZNF608 NR2F1 | 7.46e-06 | 1245 | 38 | 11 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 7.50e-06 | 413 | 38 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.04e-06 | 591 | 38 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.54e-06 | 596 | 38 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 8.68e-06 | 73 | 38 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL23A1 COL4A4 CRYBB1 COL4A5 COL5A1 COL6A1 COL11A1 COL1A1 COL1A2 | 8.83e-06 | 799 | 38 | 9 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | BM Top 100 - mammary gland | 9.17e-06 | 74 | 38 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 1.07e-05 | 615 | 38 | 8 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.41e-05 | 455 | 38 | 7 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.47e-05 | 642 | 38 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.60e-05 | 464 | 38 | 7 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.64e-05 | 652 | 38 | 8 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.64e-05 | 466 | 38 | 7 | GSM777050_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.69e-05 | 655 | 38 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.69e-05 | 655 | 38 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | COL3A1 CRYBB1 COL6A1 COL9A2 COL9A3 COL17A1 TTN COL1A1 COL1A2 | 1.87e-05 | 878 | 38 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 2.18e-05 | 92 | 38 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 2.24e-05 | 489 | 38 | 7 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 2.36e-05 | 493 | 38 | 7 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.44e-05 | 330 | 38 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 2.47e-05 | 95 | 38 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.68e-05 | 97 | 38 | 4 | GSM777046_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.70e-05 | 336 | 38 | 6 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 2.79e-05 | 98 | 38 | 4 | Arv_EB-LF_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 2.91e-05 | 99 | 38 | 4 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 3.17e-05 | 206 | 38 | 5 | JC_fibro_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.71e-05 | 731 | 38 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SHANK1 EPHB4 COL23A1 COL5A1 COL7A1 COL9A3 COL11A1 COL6A6 NR2F1 COL1A2 | 3.74e-05 | 1208 | 38 | 10 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | SHANK1 COL3A1 COL6A1 COL7A1 COL9A2 COL17A1 TTN COL1A1 COL1A2 | 4.01e-05 | 967 | 38 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 4.01e-05 | 967 | 38 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | SHANK1 COL3A1 COL6A1 COL7A1 COL9A2 COL17A1 TTN COL1A1 COL1A2 | 4.01e-05 | 967 | 38 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.38e-05 | 978 | 38 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 4.59e-05 | 984 | 38 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 BSN NR2F1 COL1A1 COL1A2 | 4.67e-05 | 986 | 38 | 9 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | COL3A1 COL5A1 COL5A3 COL7A1 COL11A1 SPOCD1 NR2F1 COL1A1 COL1A2 | 4.82e-05 | 990 | 38 | 9 | JC_fibro_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL11A1 COL6A6 SPOCD1 NR2F1 COL1A1 COL1A2 | 4.97e-05 | 994 | 38 | 9 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.24e-05 | 229 | 38 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 5.41e-05 | 116 | 38 | 4 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 5.59e-05 | 117 | 38 | 4 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.79e-05 | 123 | 38 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 7.74e-05 | 406 | 38 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 7.93e-05 | 814 | 38 | 8 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.09e-04 | 139 | 38 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.15e-04 | 141 | 38 | 4 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.37e-04 | 281 | 38 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.37e-04 | 281 | 38 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.44e-04 | 284 | 38 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | COL2A1 SHANK1 COL3A1 COL23A1 COL5A1 COL11A1 COL6A6 NR2F1 COL1A2 | 1.50e-04 | 1148 | 38 | 9 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.59e-04 | 290 | 38 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.67e-04 | 293 | 38 | 5 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.86e-04 | 300 | 38 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 2.04e-04 | 64 | 38 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.09e-04 | 487 | 38 | 6 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 2.14e-04 | 489 | 38 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 2.14e-04 | 65 | 38 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.16e-04 | 166 | 38 | 4 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 2.26e-04 | 494 | 38 | 6 | JC_fibro_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 2.31e-04 | 496 | 38 | 6 | PCBC_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.31e-04 | 496 | 38 | 6 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 2.31e-04 | 496 | 38 | 6 | Arv_EB-LF_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.33e-04 | 497 | 38 | 6 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 2.36e-04 | 498 | 38 | 6 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 2.45e-04 | 68 | 38 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.48e-04 | 319 | 38 | 5 | gudmap_developingGonad_P2_testes_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | COL2A1 SHANK1 EPHB4 COL23A1 COL5A1 COL9A3 COL11A1 PNPLA7 COL6A6 | 2.49e-04 | 1228 | 38 | 9 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.51e-04 | 320 | 38 | 5 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 2.60e-04 | 967 | 38 | 8 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 2.64e-04 | 175 | 38 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.66e-04 | 726 | 38 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | BM Top 100 - ovary | 2.66e-04 | 70 | 38 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 2.66e-04 | 70 | 38 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 2.75e-04 | 975 | 38 | 8 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 2.78e-04 | 71 | 38 | 3 | BM Top 100 - stomach fundus | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL7A1 PAWR COL11A1 NR2F1 COL1A1 COL1A2 | 1.57e-19 | 195 | 40 | 12 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.89e-19 | 198 | 40 | 12 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 NR2F1 COL1A1 COL1A2 | 1.49e-17 | 194 | 40 | 11 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL11A1 COL11A2 COL1A1 COL1A2 | 1.58e-17 | 195 | 40 | 11 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 9.69e-16 | 188 | 40 | 10 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL17A1 COL6A6 COL1A1 COL1A2 | 1.14e-15 | 191 | 40 | 10 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 PAWR NR2F1 COL1A1 COL1A2 | 1.48e-15 | 196 | 40 | 10 | cb61757646653f89faba503cb5d99e5dd5197b4c |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 PAWR NR2F1 COL1A1 COL1A2 | 1.48e-15 | 196 | 40 | 10 | 44e2df1b61e3819eae7e482bef0a733afe852d67 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A5 COL5A1 COL6A1 COL5A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.64e-15 | 198 | 40 | 10 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 NR2F1 COL1A1 COL1A2 | 1.72e-15 | 199 | 40 | 10 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 NR2F1 COL1A1 COL1A2 | 1.81e-15 | 200 | 40 | 10 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL11A1 COL11A2 NR2F1 COL1A2 | 1.81e-15 | 200 | 40 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL3A1 COL5A1 COL6A1 COL5A3 COL9A3 PNPLA7 NR2F1 COL1A1 COL1A2 | 1.52e-14 | 157 | 40 | 9 | f147e24f2ece82e1c54750868954d09b3c461804 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 4.53e-14 | 177 | 40 | 9 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 4.53e-14 | 177 | 40 | 9 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL5A3 COL1A1 COL1A2 | 5.27e-14 | 180 | 40 | 9 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL3A1 COL5A1 COL6A1 COL5A3 COL11A1 COL17A1 COL6A6 COL1A1 COL1A2 | 9.04e-14 | 191 | 40 | 9 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL6A1 COL5A3 COL1A2 | 9.48e-14 | 192 | 40 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A2 COL4A5 COL5A1 COL6A1 COL5A3 COL6A6 COL1A1 COL1A2 | 9.48e-14 | 192 | 40 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL6A1 COL5A3 COL1A2 | 9.94e-14 | 193 | 40 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | COL3A1 COL4A1 COL5A1 COL6A1 COL11A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A5 COL5A1 COL6A1 COL5A3 ZNF385A COL6A6 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A5 COL5A1 COL6A1 COL5A3 ZNF385A COL6A6 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL23A1 COL4A5 COL5A1 COL6A1 COL5A3 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL4A1 COL23A1 COL4A5 COL5A1 COL6A1 COL5A3 COL1A1 COL1A2 | 1.04e-13 | 194 | 40 | 9 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.14e-13 | 196 | 40 | 9 | af206bb5bbb8b604a6212acd79878bcc3d326cec |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 COL7A1 COL1A1 COL1A2 | 1.14e-13 | 196 | 40 | 9 | 12d9028f90c057c6e5cff00301793fa550e86c5a |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 COL1A1 COL1A2 | 1.14e-13 | 196 | 40 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 NR2F1 COL1A1 COL1A2 | 1.20e-13 | 197 | 40 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL5A3 NR2F1 COL1A1 COL1A2 | 1.20e-13 | 197 | 40 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL11A1 COL1A1 COL1A2 | 1.20e-13 | 197 | 40 | 9 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.25e-13 | 198 | 40 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 NR2F1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL11A1 NR2F1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 12133087eae9f0e9b6c13a71e8187117768e64ce |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL11A1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 63eb2106bb6e2e33d020628583536c8d96662c84 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL3A1 COL4A1 COL23A1 COL4A2 COL4A5 COL5A1 COL6A1 COL1A1 COL1A2 | 1.31e-13 | 199 | 40 | 9 | 3368c0a90a47c4dcdfe70be3192550df0744e508 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.37e-13 | 200 | 40 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 COL1A1 COL1A2 | 1.37e-13 | 200 | 40 | 9 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A6 NR2F1 COL1A1 COL1A2 | 1.37e-13 | 200 | 40 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL4A1 COL4A2 COL5A1 COL6A1 COL5A3 COL6A6 COL1A1 COL1A2 | 1.37e-13 | 200 | 40 | 9 | 76f3043cb88071256ff661885fe5a82a54f5b733 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-12 | 158 | 40 | 8 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.65e-12 | 162 | 40 | 8 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-12 | 165 | 40 | 8 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-12 | 167 | 40 | 8 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-12 | 167 | 40 | 8 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-12 | 167 | 40 | 8 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-12 | 169 | 40 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-12 | 171 | 40 | 8 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-12 | 180 | 40 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-12 | 180 | 40 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-12 | 180 | 40 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-12 | 181 | 40 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-12 | 181 | 40 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 4.23e-12 | 182 | 40 | 8 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-12 | 183 | 40 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-12 | 183 | 40 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-12 | 183 | 40 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.82e-12 | 185 | 40 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.82e-12 | 185 | 40 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.26e-12 | 187 | 40 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-12 | 187 | 40 | 8 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.49e-12 | 188 | 40 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.49e-12 | 188 | 40 | 8 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-12 | 188 | 40 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.73e-12 | 189 | 40 | 8 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-12 | 189 | 40 | 8 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 5.73e-12 | 189 | 40 | 8 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.73e-12 | 189 | 40 | 8 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.73e-12 | 189 | 40 | 8 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.73e-12 | 189 | 40 | 8 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.97e-12 | 190 | 40 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-12 | 190 | 40 | 8 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.23e-12 | 191 | 40 | 8 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-12 | 191 | 40 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.23e-12 | 191 | 40 | 8 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.23e-12 | 191 | 40 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.23e-12 | 191 | 40 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-12 | 192 | 40 | 8 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.50e-12 | 192 | 40 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.50e-12 | 192 | 40 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.50e-12 | 192 | 40 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.50e-12 | 192 | 40 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-12 | 192 | 40 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-12 | 193 | 40 | 8 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-12 | 193 | 40 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| Computational | Adhesion molecules. | COL3A1 COL4A1 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL1A1 | 1.17e-12 | 141 | 28 | 10 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.59e-09 | 50 | 28 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Neighborhood of CDH11 | 4.22e-09 | 25 | 28 | 5 | GNF2_CDH11 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.61e-07 | 50 | 28 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of PTX3 | 2.05e-06 | 36 | 28 | 4 | GNF2_PTX3 | |
| Computational | Spinal cord (neuro-development) genes. | 2.53e-06 | 360 | 28 | 8 | MODULE_12 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.81e-06 | 50 | 28 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | ECM and collagens. | 2.02e-05 | 225 | 28 | 6 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.86e-04 | 50 | 28 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Ovary genes. | 3.07e-04 | 368 | 28 | 6 | MODULE_1 | |
| Computational | Bone remodeling. | 3.59e-04 | 54 | 28 | 3 | MODULE_234 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 9.25e-04 | 453 | 28 | 6 | MODULE_24 | |
| Computational | Genes in the cancer module 55. | 9.57e-04 | 832 | 28 | 8 | MODULE_55 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 9.80e-04 | 835 | 28 | 8 | MODULE_88 | |
| Computational | Placenta genes. | 1.04e-03 | 463 | 28 | 6 | MODULE_38 | |
| Computational | Genes in the cancer module 153. | 3.49e-03 | 34 | 28 | 2 | MODULE_153 | |
| Drug | GK-101 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.82e-36 | 36 | 40 | 16 | CID000161853 |
| Drug | Madecassol | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.44e-34 | 46 | 40 | 16 | CID000108062 |
| Drug | d-indobufen | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.21e-33 | 50 | 40 | 16 | CID000044562 |
| Drug | ridogrel | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.54e-33 | 52 | 40 | 16 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.63e-33 | 53 | 40 | 16 | CID000023340 |
| Drug | AC1LAKND | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 6.62e-32 | 62 | 40 | 16 | CID000470146 |
| Drug | halofuginone lactate | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 8.00e-32 | 85 | 40 | 17 | CID000062891 |
| Drug | BAPN | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 7.68e-31 | 71 | 40 | 16 | CID000001647 |
| Drug | malotilate | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 7.68e-31 | 71 | 40 | 16 | CID000004006 |
| Drug | AC1NMZ1B | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.04e-30 | 75 | 40 | 16 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.26e-30 | 77 | 40 | 16 | CID006918182 |
| Drug | hydroxylysine | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 MBL2 COL1A1 COL1A2 | 7.99e-30 | 109 | 40 | 17 | CID000001029 |
| Drug | PPACK | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.54e-29 | 113 | 40 | 17 | CID003036757 |
| Drug | 4-hydroxyproline | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 6.13e-29 | 91 | 40 | 16 | CID000000825 |
| Drug | DMSe | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL5A3 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.57e-28 | 132 | 40 | 17 | CID000020796 |
| Drug | ticlopidine | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 5.22e-28 | 103 | 40 | 16 | CID000005472 |
| Drug | PCR 4099 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 6.51e-28 | 139 | 40 | 17 | CID000002806 |
| Drug | AC1L1C2F | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.61e-27 | 110 | 40 | 16 | CID000001711 |
| Drug | foscarnet | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 BSN RPH3A COL1A1 COL1A2 | 1.63e-27 | 190 | 40 | 18 | CID000003414 |
| Drug | AC1L9732 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.97e-27 | 114 | 40 | 16 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.44e-27 | 115 | 40 | 16 | CID000005527 |
| Drug | Selara | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.42e-26 | 125 | 40 | 16 | CID000150310 |
| Drug | khellin | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 CRYBB1 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.61e-26 | 171 | 40 | 17 | CID000003828 |
| Drug | pirfenidone | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 7.52e-26 | 138 | 40 | 16 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 8.49e-26 | 139 | 40 | 16 | CID000004727 |
| Drug | candesartan cilexetil | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.72e-25 | 145 | 40 | 16 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.10e-24 | 162 | 40 | 16 | CID000072363 |
| Drug | AC1Q6PCP | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 NR2F1 COL1A1 COL1A2 | 4.72e-24 | 230 | 40 | 17 | CID000005267 |
| Drug | AC1L1DD6 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 5.74e-24 | 179 | 40 | 16 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.41e-23 | 189 | 40 | 16 | CID000001413 |
| Drug | prostacyclin sodium salt | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.37e-21 | 250 | 40 | 16 | CID000000159 |
| Drug | hyaluronan | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.12e-21 | 263 | 40 | 16 | CID000024759 |
| Drug | silibinin | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.14e-20 | 285 | 40 | 16 | CID000005213 |
| Drug | colchine | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 BSN COL1A1 COL1A2 | 3.03e-20 | 383 | 40 | 17 | CID000002833 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 5.45e-20 | 314 | 40 | 16 | CID000447989 |
| Drug | AC1L18QD | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 9.47e-20 | 325 | 40 | 16 | CID000000213 |
| Drug | Y-27632 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.70e-19 | 444 | 40 | 17 | CID000005711 |
| Drug | losartan | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.06e-18 | 378 | 40 | 16 | CID000003961 |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.20e-18 | 476 | 40 | 17 | CID000030956 |
| Drug | chondroitin sulfate | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 4.35e-18 | 413 | 40 | 16 | CID000024766 |
| Drug | L-3,4-dehydroproline | COL2A1 COL3A1 COL23A1 COL5A1 COL6A1 COL7A1 COL9A3 COL11A1 COL1A1 COL1A2 | 4.74e-17 | 73 | 40 | 10 | CID000094284 |
| Drug | LMWH | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 PAWR COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 3.02e-16 | 663 | 40 | 17 | CID000000772 |
| Drug | aspirin | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 5.75e-16 | 563 | 40 | 16 | CID000002244 |
| Drug | pyridinoline | COL2A1 COL3A1 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 COL1A2 | 1.15e-15 | 99 | 40 | 10 | CID000105068 |
| Drug | NC-4 | 7.28e-15 | 44 | 40 | 8 | CID006420119 | |
| Drug | 1h00 | 5.75e-14 | 56 | 40 | 8 | CID000445950 | |
| Drug | BPAT-143 | 7.74e-14 | 6 | 40 | 5 | CID000146249 | |
| Drug | dermatan sulfate | COL2A1 COL3A1 COL4A3 COL4A5 COL5A1 COL6A1 COL9A2 COL9A3 COL11A1 COL11A2 COL1A1 | 9.64e-14 | 220 | 40 | 11 | CID000032756 |
| Drug | isodesmosine | 1.23e-13 | 33 | 40 | 7 | CID000013811 | |
| Drug | LS-63783 | COL2A1 COL3A1 COL4A1 COL23A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 1.44e-13 | 804 | 40 | 16 | CID000000231 |
| Drug | 4-aminoazobenzene | 2.30e-13 | 66 | 40 | 8 | CID000006051 | |
| Drug | 351A | 7.56e-13 | 20 | 40 | 6 | CID000122144 | |
| Drug | desmosine | 4.31e-12 | 53 | 40 | 7 | CID000025435 | |
| Drug | Collagenase | 8.16e-12 | 4 | 40 | 4 | DB00048 | |
| Drug | PD123177 | 1.15e-10 | 43 | 40 | 6 | CID000114899 | |
| Drug | sodium chloride | COL3A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL9A2 COL9A3 COL11A1 COL17A1 MBL2 COL1A1 COL1A2 | 1.46e-09 | 865 | 40 | 13 | CID000000206 |
| Drug | Sirius red | 4.03e-09 | 35 | 40 | 5 | CID005486818 | |
| Drug | AC1MRIIV | 7.12e-09 | 39 | 40 | 5 | CID003518584 | |
| Drug | ascorbate-2-phosphate | 1.10e-08 | 15 | 40 | 4 | ctd:C011669 | |
| Drug | AC1L9HPX | 1.27e-08 | 92 | 40 | 6 | CID000445279 | |
| Drug | 1zd2 | 1.50e-08 | 45 | 40 | 5 | CID004149241 | |
| Drug | NSC-333492 | 2.01e-08 | 4 | 40 | 3 | CID000333256 | |
| Drug | Paclitaxel | COL3A1 COL4A1 COL4A2 COL6A1 COL7A1 PAWR COL11A2 ZNF385A COL17A1 COL1A1 COL1A2 | 2.94e-08 | 720 | 40 | 11 | ctd:D017239 |
| Drug | trapidil | 5.06e-08 | 57 | 40 | 5 | CID000005531 | |
| Drug | AC1Q641C | 7.77e-08 | 62 | 40 | 5 | CID000005005 | |
| Drug | Diphosphonates | 1.00e-07 | 6 | 40 | 3 | ctd:D004164 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.00e-07 | 6 | 40 | 3 | ctd:C502971 | |
| Drug | Rgd Peptide | 1.79e-07 | 239 | 40 | 7 | CID000104802 | |
| Drug | selenomethylselenocysteine | 2.48e-07 | 78 | 40 | 5 | ctd:C002979 | |
| Drug | YIGSR | 2.65e-07 | 79 | 40 | 5 | CID000123977 | |
| Drug | etodolac | 2.83e-07 | 32 | 40 | 4 | CID000003308 | |
| Drug | isocycloheximide | COL2A1 COL3A1 COL5A1 COL6A1 COL5A3 COL7A1 COL11A1 COL11A2 COL17A1 COL1A1 COL1A2 | 2.96e-07 | 905 | 40 | 11 | CID000002900 |
| Drug | homocystine | 3.19e-07 | 82 | 40 | 5 | CID000010010 | |
| Drug | diphenylamine-2-carboxylate | 3.99e-07 | 164 | 40 | 6 | CID000004386 | |
| Drug | azelastine | 4.19e-07 | 9 | 40 | 3 | ctd:C020976 | |
| Drug | fluoride | 4.96e-07 | 278 | 40 | 7 | CID000014917 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 5.09e-07 | 90 | 40 | 5 | CID015942693 | |
| Drug | D3273 | 6.32e-07 | 94 | 40 | 5 | CID005464587 | |
| Drug | deoxypyridinoline | 7.78e-07 | 98 | 40 | 5 | CID000105071 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 7.84e-07 | 184 | 40 | 6 | 2758_UP | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.13e-06 | 196 | 40 | 6 | 4409_UP | |
| Drug | dimethylnitrosamine | 1.13e-06 | 196 | 40 | 6 | CID000006124 | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.17e-06 | 197 | 40 | 6 | 2773_UP | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 2.08e-06 | 52 | 40 | 4 | ctd:C573693 | |
| Drug | rhamnose | 2.58e-06 | 356 | 40 | 7 | CID000000840 | |
| Drug | kalinin | 2.61e-06 | 55 | 40 | 4 | CID000032518 | |
| Drug | NOC 18 | 2.77e-06 | 16 | 40 | 3 | ctd:C093285 | |
| Drug | glucosylgalactosylhydroxylysine | 2.77e-06 | 16 | 40 | 3 | CID000122304 | |
| Drug | 5'-methylthioadenosine | 3.01e-06 | 2 | 40 | 2 | ctd:C008500 | |
| Drug | AC1L9INI | 3.47e-06 | 59 | 40 | 4 | CID000445839 | |
| Drug | 17-isoprogesterone | COL2A1 COL3A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL1A1 COL1A2 | 3.67e-06 | 1170 | 40 | 11 | CID000004920 |
| Drug | mitomycin C | 3.75e-06 | 241 | 40 | 6 | CID000005746 | |
| Drug | gold nanoparticles | 3.94e-06 | 243 | 40 | 6 | CID000023985 | |
| Drug | Pz-plgpa | 4.77e-06 | 19 | 40 | 3 | CID000152296 | |
| Drug | Spurr resin | 4.81e-06 | 64 | 40 | 4 | CID006449895 | |
| Drug | arabinosyladenine | 5.41e-06 | 762 | 40 | 9 | CID000000191 | |
| Drug | 3-hydroxy-L-proline | 5.61e-06 | 20 | 40 | 3 | CID000150779 | |
| Drug | Se-methylselenocysteine | 6.13e-06 | 68 | 40 | 4 | CID000114835 | |
| Drug | calcium phosphate | 6.14e-06 | 149 | 40 | 5 | CID000024441 | |
| Drug | n-butoxyethanol | 6.41e-06 | 581 | 40 | 8 | ctd:C017096 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.58e-15 | 53 | 40 | 8 | C4707243 | |
| Disease | Stickler syndrome, type 1 | 1.45e-11 | 5 | 40 | 4 | C2020284 | |
| Disease | Stickler syndrome | 1.45e-11 | 5 | 40 | 4 | cv:C0265253 | |
| Disease | Disproportionate short stature | 9.26e-10 | 77 | 40 | 6 | C0878659 | |
| Disease | Hereditary hearing loss and deafness | 1.02e-09 | 146 | 40 | 7 | cv:C0236038 | |
| Disease | collagen disease (implicated_via_orthology) | 1.42e-09 | 12 | 40 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Alport syndrome | 2.31e-09 | 3 | 40 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 2.31e-09 | 3 | 40 | 3 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 9.22e-09 | 4 | 40 | 3 | C0241908 | |
| Disease | Stickler syndrome (is_implicated_in) | 9.22e-09 | 4 | 40 | 3 | DOID:0080046 (is_implicated_in) | |
| Disease | Alport Syndrome | 9.22e-09 | 4 | 40 | 3 | C1567741 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.11e-08 | 19 | 40 | 4 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 1.38e-08 | 20 | 40 | 4 | C0026760 | |
| Disease | Ehlers-Danlos Syndrome | 2.30e-08 | 5 | 40 | 3 | C0013720 | |
| Disease | Alport Syndrome, X-Linked | 2.30e-08 | 5 | 40 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 2.30e-08 | 5 | 40 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 2.30e-08 | 5 | 40 | 3 | C1567744 | |
| Disease | Intervertebral disc disorder | 4.60e-08 | 6 | 40 | 3 | C0158252 | |
| Disease | Cleft Palate | 8.39e-08 | 81 | 40 | 5 | C0008925 | |
| Disease | Ehlers-Danlos syndrome | 1.29e-07 | 8 | 40 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.93e-07 | 9 | 40 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | end stage renal disease (is_implicated_in) | 2.83e-07 | 41 | 40 | 4 | DOID:783 (is_implicated_in) | |
| Disease | Early Pregnancy Loss | 3.72e-07 | 109 | 40 | 5 | C3830362 | |
| Disease | Miscarriage | 3.72e-07 | 109 | 40 | 5 | C4552766 | |
| Disease | Spontaneous abortion | 3.72e-07 | 109 | 40 | 5 | C0000786 | |
| Disease | Abortion, Tubal | 3.72e-07 | 109 | 40 | 5 | C0000822 | |
| Disease | myopathy (implicated_via_orthology) | 5.39e-07 | 48 | 40 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 6.54e-07 | 13 | 40 | 3 | C0009782 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | benign familial hematuria (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Fibrochondrogenesis | 1.79e-06 | 2 | 40 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 1.79e-06 | 2 | 40 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 1.79e-06 | 2 | 40 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 1.79e-06 | 2 | 40 | 2 | C0302892 | |
| Disease | Alport syndrome, recessive type | 1.79e-06 | 2 | 40 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.79e-06 | 2 | 40 | 2 | C2931253 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 1.79e-06 | 2 | 40 | 2 | C0268345 | |
| Disease | Megaepiphyseal dwarfism | 1.79e-06 | 2 | 40 | 2 | C1855310 | |
| Disease | Porencephaly | 1.79e-06 | 2 | 40 | 2 | C4082173 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 1.79e-06 | 2 | 40 | 2 | C4520892 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 1.79e-06 | 2 | 40 | 2 | C4551623 | |
| Disease | PORENCEPHALY, FAMILIAL | 1.79e-06 | 2 | 40 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.79e-06 | 2 | 40 | 2 | C3281105 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.79e-06 | 2 | 40 | 2 | C4746745 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.79e-06 | 2 | 40 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.79e-06 | 2 | 40 | 2 | cv:C0241908 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.79e-06 | 2 | 40 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.79e-06 | 2 | 40 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 1.79e-06 | 2 | 40 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 1.79e-06 | 2 | 40 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 1.79e-06 | 2 | 40 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 1.79e-06 | 2 | 40 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 1.79e-06 | 2 | 40 | 2 | cv:C0268358 | |
| Disease | Stickler syndrome, type 3 | 1.79e-06 | 2 | 40 | 2 | C1861481 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 1.79e-06 | 2 | 40 | 2 | 259420 | |
| Disease | Renal glomerular disease | 4.01e-06 | 23 | 40 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 4.01e-06 | 23 | 40 | 3 | C4521256 | |
| Disease | Stickler syndrome (disorder) | 5.37e-06 | 3 | 40 | 2 | C0265253 | |
| Disease | Alport syndrome (is_implicated_in) | 5.37e-06 | 3 | 40 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 5.37e-06 | 3 | 40 | 2 | C4552122 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 5.37e-06 | 3 | 40 | 2 | C0220679 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 5.37e-06 | 3 | 40 | 2 | cv:C3281105 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 5.37e-06 | 3 | 40 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 5.37e-06 | 3 | 40 | 2 | 614519 | |
| Disease | Nephrotic Syndrome | 6.60e-06 | 27 | 40 | 3 | C0027726 | |
| Disease | Liver Cirrhosis, Experimental | 7.91e-06 | 774 | 40 | 8 | C0023893 | |
| Disease | Disorder of eye | 9.79e-06 | 212 | 40 | 5 | C0015397 | |
| Disease | OSTEOPOROSIS | 1.07e-05 | 4 | 40 | 2 | 166710 | |
| Disease | Keloid | 1.47e-05 | 35 | 40 | 3 | C0022548 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 1.79e-05 | 5 | 40 | 2 | C0268358 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 1.79e-05 | 5 | 40 | 2 | cv:CN043640 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | INTERVERTEBRAL DISC DISEASE | 1.79e-05 | 5 | 40 | 2 | 603932 | |
| Disease | Lumbar disc disease | 1.79e-05 | 5 | 40 | 2 | C0221775 | |
| Disease | Intervertebral disc disorder | 1.79e-05 | 5 | 40 | 2 | cv:C0158252 | |
| Disease | Lobstein Disease | 1.79e-05 | 5 | 40 | 2 | C0023931 | |
| Disease | Osteoporosis | 2.68e-05 | 6 | 40 | 2 | cv:C0029456 | |
| Disease | Cartilage Diseases | 2.68e-05 | 6 | 40 | 2 | C0007302 | |
| Disease | hypertensive nephropathy | 2.68e-05 | 6 | 40 | 2 | C0848548 | |
| Disease | Chondromalacia | 2.68e-05 | 6 | 40 | 2 | C0085700 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 2.68e-05 | 6 | 40 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 3.75e-05 | 7 | 40 | 2 | C1846545 | |
| Disease | Bleeding tendency | 3.75e-05 | 7 | 40 | 2 | C1458140 | |
| Disease | Fibrosis | 4.33e-05 | 50 | 40 | 3 | C0016059 | |
| Disease | Cirrhosis | 4.33e-05 | 50 | 40 | 3 | C1623038 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 6.41e-05 | 9 | 40 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Hematuria | 6.41e-05 | 9 | 40 | 2 | C0018965 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 8.01e-05 | 10 | 40 | 2 | C0268363 | |
| Disease | arterial stiffness measurement | 9.08e-05 | 64 | 40 | 3 | EFO_0004517 | |
| Disease | Nephrosclerosis | 9.78e-05 | 11 | 40 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 9.78e-05 | 11 | 40 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 9.78e-05 | 11 | 40 | 2 | C0268362 | |
| Disease | Sensory hearing loss | 9.78e-05 | 11 | 40 | 2 | C1691779 | |
| Disease | keratoconus | 9.95e-05 | 66 | 40 | 3 | MONDO_0015486 | |
| Disease | mental or behavioural disorder | 1.01e-04 | 179 | 40 | 4 | EFO_0000677 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLGPAPGSPEKQPGS | 146 | Q96PM9 | |
| PSGDPGKPGLTGPQG | 771 | Q9UMD9 | |
| KDGQDGAPGEPGPPG | 631 | Q14050 | |
| PPGSPGQKGFTGPEG | 56 | Q01955 | |
| EKGDQGPPGDPGSPG | 591 | Q01955 | |
| NPGPDTKGKGAPPAG | 16 | P53674 | |
| GPKGFPGPQGAPGLS | 686 | P53420 | |
| GSEGFTGPPGPQGPK | 151 | P08572 | |
| SGSPGENGSPGPMGP | 311 | P02458 | |
| GTPGSPGPAGASGNP | 396 | P02458 | |
| KGASGPAGPPGAQGP | 731 | P02458 | |
| LPGPPGPSGDQGASG | 1141 | P02458 | |
| PGPQGSPGLPGDKGA | 1031 | P02462 | |
| PGPTGPAGQKGEPGS | 1141 | P02462 | |
| GGPPGFASSSGKPGP | 841 | Q9NTZ6 | |
| PPGGGSSDAAGKPPA | 41 | Q96IZ0 | |
| PATPGTAGDKGQGPP | 61 | P10589 | |
| QAKPGTPGGTGGPAP | 971 | P54760 | |
| PGAGKPPSAPAGGGQ | 31 | Q9UPA5 | |
| PGPQGPKGNKGSTGP | 1506 | P12107 | |
| GKKGDDGTPSQPGPP | 241 | Q86Y22 | |
| EGPPGTKGNQGPSGP | 696 | P13942 | |
| LKGNEGPSGPPGPAG | 1001 | P13942 | |
| PGPKGPTGDDGPKGN | 1251 | P13942 | |
| PTGDDGPKGNPGPVG | 1256 | P13942 | |
| NPGPSGSPGPKGQKG | 81 | P11226 | |
| KPGAGDPDPSAPQGG | 371 | Q6ZV29 | |
| AGPQGPPGPSGEEGK | 366 | P08123 | |
| NIGFPGPKGPTGDPG | 491 | P08123 | |
| KGSPGFDGIQGPPGP | 346 | P12109 | |
| PGPPGSPGDKGLQGE | 456 | P29400 | |
| GSPGPALEGPKGNPG | 1241 | P29400 | |
| PQGLPGFSGPPGKEG | 356 | Q14055 | |
| GPKGNSGGDGPAGPP | 931 | P20908 | |
| GEPGPAGQDGPPGDK | 1351 | P20908 | |
| PGAKASNPFLPGGGP | 496 | Q9Y6I3 | |
| GKGAAGPPGPPGAAG | 706 | P02461 | |
| SGSPGKDGPPGPAGN | 896 | P02461 | |
| KDGPPGPAGNTGAPG | 901 | P02461 | |
| EKGSPGAQGPPGAPG | 931 | P02461 | |
| GAPGPQGPPGSATAK | 1281 | Q02388 | |
| FPGPSGNDGSAGPPG | 2711 | Q02388 | |
| GNDGSAGPPGPPGSV | 2716 | Q02388 | |
| DKGPPGPVGANGSPG | 996 | P25940 | |
| SKGPQGPPGPGGEAG | 1601 | A6NMZ7 | |
| GAAGPPPGGSNATGP | 71 | P0DMQ5 | |
| GGGPDGEQPTGPPSA | 686 | P84550 | |
| GPGQKTGPDPASAPG | 211 | Q9Y2J0 | |
| GGPFNPGSGGPLPAS | 951 | Q9Y566 | |
| GPPGPPGKNGDDGEA | 221 | P02452 | |
| GPAGPKGEPGSPGEN | 281 | P02452 | |
| QGPGGPPGPKGNSGE | 421 | P02452 | |
| PPGADGQPGAKGEPG | 816 | P02452 | |
| GFPGLPGPSGEPGKQ | 971 | P02452 | |
| PGPSGEPGKQGPSGA | 976 | P02452 | |
| GPPGSPGEQGPSGAS | 1121 | P02452 | |
| PGEQGPSGASGPAGP | 1126 | P02452 | |
| !!! TO LONG IT | 1 | Q8WZ42 | |
| PPGDPKDGPMGNSGG | 216 | Q9C0A1 | |
| PGLSPDGPGASSGPG | 36 | Q6ZMY3 | |
| SLPQPEPPGGGGSKG | 651 | Q9UGU0 | |
| GSGPPPPAGGAGSRD | 541 | Q2VWA4 | |
| ASPGAGNPPGTPKGK | 626 | Q9ULD9 |